# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Vivos Therapeutics (NASDAQ:VVOS) reported quarterly losses of $(1.63) per share. This is a 5.23 percent increase over losses of...
Vivos Therapeutics shares are trading lower Tuesday. The company filed a prospectus related to the resale of up to 1.73 million...
LASE: 167% | Laser Photonics shares are trading higher after the company announced it secured an order for its LaserTower COMPA...
-S-1
Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ:VVOS), a leading medical device and technology company specializin...
https://patentcenter.uspto.gov/applications/17522740/ifw/docs